{
    "organizations": [],
    "uuid": "af48340baa51cc3e7a62988a42241b28e346b65f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ophthotech-completes-patient-recru/brief-ophthotech-completes-patient-recruitment-in-a-mid-stage-trial-of-its-eye-drug-zimura-idUSASC09YK4",
    "ord_in_thread": 0,
    "title": "BRIEF-Ophthotech Completes Patient Recruitment In A Mid-Stage Trial Of Its Eye Drug Zimura",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Ophthotech Corp:\n* OPHTHOTECH COMPLETES PATIENT RECRUITMENT IN THE PHASE 2A CLINICAL TRIAL OF ZIMURAÂ® IN COMBINATION WITH ANTI-VEGF THERAPY IN WET AGE-RELATED MACULAR DEGENERATION\n* OPHTHOTECH CORP - INITIAL TOP-LINE DATA EXPECTED BY END OF 2018\n* OPHTHOTECH CORP - WILL EVALUATE DATA AT MONTH 6 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-01T19:43:00.000+03:00",
    "crawled": "2018-05-02T16:08:01.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ophthotech",
        "corp",
        "ophthotech",
        "completes",
        "patient",
        "recruitment",
        "phase",
        "2a",
        "clinical",
        "trial",
        "combination",
        "therapy",
        "wet",
        "macular",
        "degeneration",
        "ophthotech",
        "corp",
        "initial",
        "data",
        "expected",
        "end",
        "ophthotech",
        "corp",
        "evaluate",
        "data",
        "month",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}